$BCCG

Blue Chip Capital Group Inc.

CIK:0001932213|SEC Filings

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	May 31, 2026	May 31, 2025
Income Statement [Abstract]
Revenues:
Operating Expenses:
Stock-based compensation	6,054,750	1,897,500
Inducement expense	13,149,650	3,134,145
General & Administrative expenses	2,535,200	589,325
Total Operating expenses	21,739,600	5,620,970
Loss from operations	(21,739,600)	(5,620,970)
Other income/(expenses):
Interest expense	(911,014)	(72,166)
Total Other income/(expenses)	(911,014)	(72,166)
NET LOSS	$ (22,650,614)	$ (5,693,136)
Net Loss Share Basic	$ (0.2354)	$ (0.0687)
Net Loss Share Diluted	$ (0.2354)	$ (0.0687)
Weighted Average Number of Common Shares Outstanding during the year Basic	96,225,126	82,902,668
Weighted Average Number of Common Shares Outstanding during the year Diluted	96,225,126	82,902,668

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	May 31, 2026	May 31, 2025
Cash Flows from Operating Activities:
Net loss	$ (22,650,614)	$ (5,693,136)
Adjustments to reconcile net loss to net cash used in operations
Shares in lieu of compensation	6,054,750	1,897,500
Shared issued for inducement	13,149,650	3,134,145
Discount amortization	752,200	50,136
Warrants for services	88,000
Changes in operating assets and liabilities:
Accounts Payable related party	235,000
Accrued officers’ compensation	330,000
Overdraft	111
Accounts payable	571,538	8,000
Accrued Interest payable	158,815	22,030
Due to related parties	5,157	(72,025)
Net Cash Used in Operating Activities	(1,305,393)	(653,350)
Cash Flows from Financing Activities:
Proceeds from sale of common stock		1,000
Note Payable borrowings	1,305,000	650,000
Net Cash Provided by Financing Activities	1,305,000	651,000
Net Increase (Decrease) in Cash	(393)	(2,350)
Cash at Beginning of Period	393	2,743
Cash at End of Period		393
Supplemental disclosure of cash flow information:
Shares issued for services	6,054,750	1,897,500
Shares issued with convertible notes	13,149,650	3,134,145
Warrants issued for services	88,000
Non-cash Investing & Financing Activities:
Warrants issued with convertible notes	$ 828,454	$ 217,650

Consolidated Balance Sheets - USD ($)	May 31, 2026	May 31, 2025
Current Assets
Cash		$ 393
Total Current Assets		393
Other Assets
Software application	88,590	88,590
Total Other Assets	88,590	88,590
Total Assets	88,590	88,983
Current Liabilities
Overdraft	111
Accrued officer Compensation	330,000
Accrued interest payable	180,843	22,030
Note Payable	320,000	35,000
Convertible notes payable, net discount of $243,767 and $167,514, respectively	1,391,232	447,486
Total Liabilities	3,139,121	609,756
Stockholders’ Deficit
Preferred A Stock, $0.0001 par value; 1,000,000 shares authorized, 999,999 issued and outstanding on May 31, 2026, and on May 31, 2025, respectively	100	100
Common stock, $0.0001 par value; 400,000,000 shares authorized 104,726,400 issued and outstanding, on May 31, 2026, and 86,289,400 on May 31, 2025.	10,473	8,629
Additional paid-in capital	27,845,723	7,726,711
Accumulated deficit	(30,906,827)	(8,256,213)
Total Stockholders’ Deficit	(3,050,531)	(520,773)
Total Liabilities and Stockholders’ Deficit	88,590	88,983
Nonrelated Party [Member]
Current Liabilities
Accounts payable	571,538
Related Party [Member]
Current Liabilities
Accounts payable	340,000	105,000
Due to related parties	$ 5,397	$ 240